FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2414747016> ?p ?o ?g. }

• W2414747016 endingPage "81" @default.
• W2414747016 startingPage "81" @default.
• W2414747016 abstract "Lymphomas constitute the second most common indication for high dose therapy (HDT) followed by autologous hematopoietic cell transplantation (auto-HCT). The intent of administering HDT in these heterogeneous disorders varies from cure (e.g., in relapsed aggressive lymphomas) to disease control (e.g., most indolent lymphomas). Regardless of the underlying histology or remission status at transplantation, disease relapse remains the number one cause of post auto-HCT therapy failure and mortality. The last decade has seen a proliferation of clinical studies looking at prevention of post auto-HCT therapy failure with various maintenance strategies. The benefit of such therapies is in turn dependent on disease histology and timing of transplantation. In relapsed, chemosensitive diffuse large B-cell lymphoma (DLBCL), although post auto-HCT maintenance rituximab seems to be safe and feasible, it does not provide improved survival outcomes and is not recommended. The preliminary results with anti- programmed death -1 (PD-1) antibody therapy as post auto-HCT maintenance in DLBCL is promising but requires randomized validation. Similarly in follicular lymphoma, maintenance therapies including rituximab following auto-HCT should be considered investigational and offered only on a clinical trial. Rituximab maintenance results in improved progression-free survival but has not yet shown to improve overall survival in mantle cell lymphoma (MCL), but given the poor prognosis with post auto-HCT failure in MCL, maintenance rituximab can be considered on a case-by-case basis. Ongoing trials evaluating the efficacy of post auto-HCT maintenance with novel compounds (e.g., immunomodulators, PD-1 inhibitors, proteasome inhibitors and bruton's tyrosine kinase inhibitors) will likely change the practice landscape in the near future for B cell non-Hodgkin lymphomas patients following HDT and auto-HCT." @default.
• W2414747016 created "2016-06-24" @default.
• W2414747016 creator A5000524361 @default.
• W2414747016 creator A5004234559 @default.
• W2414747016 creator A5011030256 @default.
• W2414747016 creator A5069393942 @default.
• W2414747016 date "2015-01-01" @default.
• W2414747016 modified "2023-10-16" @default.
• W2414747016 title "Recent advances in post autologous transplantation maintenance therapies in B-cell non-Hodgkin lymphomas" @default.
• W2414747016 cites W106664028 @default.
• W2414747016 cites W1504115866 @default.
• W2414747016 cites W1659193542 @default.
• W2414747016 cites W1842391090 @default.
• W2414747016 cites W1947079675 @default.
• W2414747016 cites W1965052170 @default.
• W2414747016 cites W1965302024 @default.
• W2414747016 cites W1986354050 @default.
• W2414747016 cites W1997353354 @default.
• W2414747016 cites W2000745246 @default.
• W2414747016 cites W2008143837 @default.
• W2414747016 cites W2013028547 @default.
• W2414747016 cites W2016553294 @default.
• W2414747016 cites W2026252130 @default.
• W2414747016 cites W2030638302 @default.
• W2414747016 cites W2034892179 @default.
• W2414747016 cites W2035029714 @default.
• W2414747016 cites W2039845134 @default.
• W2414747016 cites W2046317078 @default.
• W2414747016 cites W2048005105 @default.
• W2414747016 cites W2056952913 @default.
• W2414747016 cites W2079012552 @default.
• W2414747016 cites W2079925501 @default.
• W2414747016 cites W2086708929 @default.
• W2414747016 cites W2092586894 @default.
• W2414747016 cites W2095669071 @default.
• W2414747016 cites W2097145287 @default.
• W2414747016 cites W2098901377 @default.
• W2414747016 cites W2101648653 @default.
• W2414747016 cites W2105352757 @default.
• W2414747016 cites W2105396178 @default.
• W2414747016 cites W2111500154 @default.
• W2414747016 cites W2112077806 @default.
• W2414747016 cites W2113135984 @default.
• W2414747016 cites W2114233385 @default.
• W2414747016 cites W2115091768 @default.
• W2414747016 cites W2127749132 @default.
• W2414747016 cites W2130997237 @default.
• W2414747016 cites W2139287757 @default.
• W2414747016 cites W2141200671 @default.
• W2414747016 cites W2150587745 @default.
• W2414747016 cites W2152327309 @default.
• W2414747016 cites W2154066874 @default.
• W2414747016 cites W2156522119 @default.
• W2414747016 cites W2158250740 @default.
• W2414747016 cites W2158689824 @default.
• W2414747016 cites W2159397371 @default.
• W2414747016 cites W2162489923 @default.
• W2414747016 cites W2171891459 @default.
• W2414747016 cites W2323273449 @default.
• W2414747016 cites W2598700764 @default.
• W2414747016 doi "https://doi.org/10.5500/wjt.v5.i3.81" @default.
• W2414747016 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4580930" @default.
• W2414747016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26421260" @default.
• W2414747016 hasPublicationYear "2015" @default.
• W2414747016 type Work @default.
• W2414747016 sameAs 2414747016 @default.
• W2414747016 citedByCount "3" @default.
• W2414747016 countsByYear W24147470162016 @default.
• W2414747016 countsByYear W24147470162018 @default.
• W2414747016 countsByYear W24147470162020 @default.
• W2414747016 crossrefType "journal-article" @default.
• W2414747016 hasAuthorship W2414747016A5000524361 @default.
• W2414747016 hasAuthorship W2414747016A5004234559 @default.
• W2414747016 hasAuthorship W2414747016A5011030256 @default.
• W2414747016 hasAuthorship W2414747016A5069393942 @default.
• W2414747016 hasBestOaLocation W24147470161 @default.
• W2414747016 hasConcept C126322002 @default.
• W2414747016 hasConcept C143998085 @default.
• W2414747016 hasConcept C2776694085 @default.
• W2414747016 hasConcept C2777058707 @default.
• W2414747016 hasConcept C2777525834 @default.
• W2414747016 hasConcept C2778283404 @default.
• W2414747016 hasConcept C2779338263 @default.
• W2414747016 hasConcept C2780653079 @default.
• W2414747016 hasConcept C2911091166 @default.
• W2414747016 hasConcept C535046627 @default.
• W2414747016 hasConcept C71924100 @default.
• W2414747016 hasConceptScore W2414747016C126322002 @default.
• W2414747016 hasConceptScore W2414747016C143998085 @default.
• W2414747016 hasConceptScore W2414747016C2776694085 @default.
• W2414747016 hasConceptScore W2414747016C2777058707 @default.
• W2414747016 hasConceptScore W2414747016C2777525834 @default.
• W2414747016 hasConceptScore W2414747016C2778283404 @default.
• W2414747016 hasConceptScore W2414747016C2779338263 @default.
• W2414747016 hasConceptScore W2414747016C2780653079 @default.
• W2414747016 hasConceptScore W2414747016C2911091166 @default.
• W2414747016 hasConceptScore W2414747016C535046627 @default.
• W2414747016 hasConceptScore W2414747016C71924100 @default.

• next